References
- Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58(1):26–35.
- Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26(3):355–69.
- Michaud CM, McKenna MT, Begg S, Tomijima N, Majmudar M, Bulzacchelli MT, et al. The burden of disease and injury in the United States 1996. Popul Health Metr. 2006;4:11.
- Bannuru RR, Schmid CH, Kent DM, Vaysbrot EE, Wong JB, McAlindon TE. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med. 2015;162(1):46–54.
- Tomisato W, Tsutsumi S, Hoshino T, Hwang HJ, Mio M, Tsuchiya T, et al. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions. Biochem Pharmacol. 2004;67:575–85.
- Tomisato W, Tanaka K, Katsu T, Kakuta H, Sasaki K, Tsutsumi S, et al. Membrane permeabilization by non-steroidal anti-inflammatory drugs. Biochem Biophys Res Commun. 2004;323:1032–9.
- Sinha M, Gautam L, Shukla PK, Kaur P, Sharma S, Singh TP. Current perspectives in NSAID-induced gastropathy. Mediators Inflamm. 2013;2013:258209.
- Rolf C, Engström B, Beauchard C, Jacobs LD, Le Liboux A. Intra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopy. Rheumatology (Oxford). 1999;38(6):564–7.
- Miyatake S, Ichiyama H, Kondo E, Yasuda K. Randomized clinical comparisons of diclofenac concentration in the soft tissues and blood plasma between topical and oral applications. Br J Clin Pharmacol. 2009;67(1):125–9.
- Carabaza A, Cabré F, Rotllan E, Gómez M, Gutiérrez M, García ML, Mauleón D. Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs. J Clin Pharmacol. 1996;36(6):505–12.
- Yataba I, Otsuka N, Matsushita I, Kamezawa M, Yamada I, Sasaki S, et al. Plasma pharmacokinetics and synovial concentrations of S-flurbiprofen plaster in humans. Eur J Clin Pharmacol. 2016;72(1):53–9.
- Coetzer R. Patches for pain relief. S Afr Pharm J. 2013;80:12–15.
- Martens M. Efficacy and tolerability of a topical NSAID patch (local action transcutaneous flurbiprofen) and oral diclofenac in the treatment of soft-tissue rheumatism. Clin Rheumatol. 1997;16(1):25–31.
- European Medicines Agency. Committee for medicinal products for human use, guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis. 2010. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003440.pdf [last accessed 20 Apr 2016].
- U.S. Department Of Health And Human Services Food and Drug Administration. Guidance for industry: clinical development programs for drugs, devices, and biological products intended for the treatment of osteoarthritis (OA), draft guidance. 1999. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071577.pdf [last accessed 20 Apr 2016].
- Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494–502.
- Medicine Interview Form of Froben® (in Japanese). 2012; Version 8. Available from: http://www.info.pmda.go.jp/go/interview/1/200022_1149011D1032_1_080_1F [last accessed 20 Apr 2016].
- Nakazawa T, Shimo T, Chikamatsu N, Igarashi T, Nagata O, Yamamoto M. Study on the mechanism of photosensitive dermatitis caused by ketoprofen in the guinea pig. Arch Toxicol. 2006;80(7):442–8.
- Seto Y, Ohtake H, Kato M, Onoue S. Phototoxic risk assessments on benzophenone derivatives: photobiochemical assessments and dermal cassette-dosing pharmacokinetic study. J Pharmacol Exp Ther. 2015;354(2):195–202.